Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Exactech gets US rights to Italian bone cement:

This article was originally published in Clinica

Executive Summary

Exactech has secured exclusive US rights to market and distribute Cemex bone cement from Tecres, a Verona, Italy-based company. The one-step delivery product has been in use in Europe for 10 years and will be offered alongside Exactech's hip and knee implants. The surgical implantation bone cement market in the US is worth $100 million a year, according to Exactech, of Gainesville, Florida.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070181

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel